IRIS - Res&Arch Institutional Research Information System - Research & Archive

CALABRESI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.201
EU - Europa 9.864
AS - Asia 3.344
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 24
AF - Africa 17
OC - Oceania 7
Totale 25.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.156
UA - Ucraina 2.276
IE - Irlanda 2.106
IT - Italia 1.592
SE - Svezia 1.331
SG - Singapore 1.263
HK - Hong Kong 707
VN - Vietnam 649
DE - Germania 533
FI - Finlandia 513
CN - Cina 478
RU - Federazione Russa 430
FR - Francia 390
GB - Regno Unito 238
BR - Brasile 190
KR - Corea 86
CH - Svizzera 72
TR - Turchia 69
NL - Olanda 66
RO - Romania 64
CZ - Repubblica Ceca 58
AT - Austria 52
BE - Belgio 50
PL - Polonia 35
UZ - Uzbekistan 28
GR - Grecia 25
CA - Canada 24
EU - Europa 22
LB - Libano 20
MX - Messico 16
JP - Giappone 10
LT - Lituania 10
AU - Australia 5
AR - Argentina 4
EG - Egitto 4
IN - India 4
KZ - Kazakistan 4
MA - Marocco 4
RS - Serbia 4
VE - Venezuela 4
CI - Costa d'Avorio 3
ES - Italia 3
HU - Ungheria 3
IQ - Iraq 3
PK - Pakistan 3
BG - Bulgaria 2
CL - Cile 2
EC - Ecuador 2
IL - Israele 2
LV - Lettonia 2
MN - Mongolia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 25.663
Salva come PNG Salva come JPEG
Città #
Chandler 2.394
Dublin 2.101
Jacksonville 1.146
San Mateo 1.146
Singapore 951
Boardman 851
Hong Kong 705
Dong Ket 648
Santa Clara 563
Medford 536
Princeton 532
Altamura 490
Perugia 445
Wilmington 400
Lawrence 388
Des Moines 364
Andover 343
Ann Arbor 308
Ashburn 201
Beijing 197
Saint Petersburg 147
Norwalk 97
San Paolo di Civitate 83
Seoul 81
Falls Church 78
Los Angeles 76
Woodbridge 76
Helsinki 70
Redmond 69
Izmir 66
Bucharest 53
Shanghai 50
Brussels 49
Munich 49
Milan 48
Dearborn 45
Rome 41
Brno 39
Moscow 34
Redwood City 32
Den Haag 29
Bologna 17
Lausanne 17
Houston 16
Dallas 15
Frankfurt Am Main 14
Florence 13
Tappahannock 13
Auburn Hills 12
Edinburgh 12
Genoa 12
Modena 12
New York 12
Vienna 12
Frankfurt am Main 11
Nuremberg 11
São Paulo 10
Washington 10
Olomouc 9
Ottawa 9
Toronto 9
Ancona 8
Fairfield 8
London 8
San Diego 8
Zhengzhou 8
Amsterdam 7
Guangzhou 7
Laion 7
Seattle 7
Chicago 6
Fremont 6
Parma 6
Philadelphia 6
Terni 6
Tokyo 6
Trento 6
Nanning 5
Rio de Janeiro 5
Saint Louis 5
Turin 5
Belo Horizonte 4
Campinas 4
Carlentini 4
Cava de' Tirreni 4
Changsha 4
Curitiba 4
Foligno 4
Genova 4
Hefei 4
Kiev 4
Lucca 4
Maceió 4
Mexico City 4
Nagold 4
Naples 4
Noceto 4
Padova 4
Paris 4
Pomezia 4
Totale 16.473
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 464
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 152
CSF and blood biomarkers for Parkinson's disease 119
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 112
Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? 97
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 95
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 94
Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. 93
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 93
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 91
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 90
Phyto-oestrogens in the prophylaxis of menstrual migraine. 89
Deficits of glutamate transmission in the striatum of experimental hemiballism. 89
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. 88
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 87
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 87
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. 86
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 85
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 85
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. 84
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. 83
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 83
Migraine-specific quality of life questionnaire and relapse of medication overuse headache 83
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 83
An abnormal striatal synaptic plasticity may account for the selective neuronal vulnerability in Huntington's disease. 82
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. 82
Calcium signaling and neuronal vulnerability to ischemia in the striatum. 81
Cell-type specificity of mGluR activation in striatal neuronal subtypes. 80
Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? 80
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. 79
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 79
Modulation of gene expression following long-term synaptic depression in the striatum. 76
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. 76
Acute dystonia induced by the combination of midodrine and perphenazine. 76
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 76
Plasticity and repair in the post-ischemic brain 76
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. 75
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 75
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 75
Cerebrospinal fluid biomarkers in Parkinson disease. 75
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 75
Medication-overuse headache: similarities with drug addiction. 74
Coordinate high-frequency pattern of stimulation and calcium levels control the induction of LTP in striatal cholinergic interneurons. 73
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 73
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 73
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 73
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 73
Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: An immunohistological study. 73
Removing Pathogenic Memories: A Neurobiology of Psychotherapy. 72
Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease 72
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. 72
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. 72
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 72
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. 72
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 72
Pathological Synaptic Plasticity in the Striatum: Implications for Parkinson's Disease. 71
Language disturbances as a side effect of prophylactic treatment of migraine. 71
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 71
Clinical aspects and management of levodopa-induced dyskinesia. 71
Hippocampal epileptogenesis in autoimmune encephalitis 71
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. 70
Association between migraine and headache attributed to stroke: a case-control study. 70
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices. 70
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 69
Occipital arteriovenous malformations andmigraine. 69
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 69
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum. 69
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 69
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. 68
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. 68
Application of the ICHD-II criteria to the diagnosis of primary chronic headaches via a computerized structured record. 68
Diagnostic accuracy of Parkinson disease by Support Vector Machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age 68
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. 68
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons. 67
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 67
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 67
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors. 67
Functional interactions within striatal microcircuit in animal models of Huntington's disease. 66
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 66
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. 65
Adrenomyeloneuropathy partially responsive to steroid pulse therapy. 65
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 65
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia. 65
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 65
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. 64
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 64
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. 64
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease. 64
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 64
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 64
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 63
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 63
Application of ICHD 2nd edition criteria for primary headaches with the aid of a computerised, structured medical record for the specialist. 63
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. 62
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 62
Effects of glycine on neurons in the rat substantia nigra zona compacta: in vitro electrophysiological study. 62
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway. 62
A magnetization transfer study of mild and advanced Parkinson's disease. 62
Endogenous Ach enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 61
The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. 61
Totale 7.926
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020952 0 0 0 0 0 0 0 82 368 208 46 248
2020/20214.643 23 335 176 336 1.366 263 293 73 535 153 370 720
2021/20224.441 88 792 110 257 135 55 55 1.426 88 162 475 798
2022/20237.812 619 1.433 157 640 587 979 10 314 2.708 20 258 87
2023/20242.715 166 310 154 59 31 18 433 134 361 92 449 508
2024/20252.847 115 670 231 271 814 326 311 109 0 0 0 0
Totale 26.784